Indian American’s business receives US$400,000 NCI/NIH Grant to treat lung cancer
Three company's immunotherapy program does not use viruses that are conventionally used for treatments of such kind, it has the potential to become the first of its kind approach for cancer immunotherapy.
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login